Monitoring in Subarachnoid Haemorrhage
Monitoring in the critically ill subarachnoid haemorrhage patient is primarily to detect vasospasm.
Monitoring in the critically ill subarachnoid haemorrhage patient is primarily to detect vasospasm.
Neurosurgery Literature Summaries
SAH Complications including Neurological deterioration; Seizures; Hyponatremia; Cardiac complications; Re-bleeding; Vasospasm
Subarachnoid Haemorrhage Grading Systems: GCS; Hunt and Hess; WFNS; Fisher; Claassen; Ogilvy and Carter
SAH ICU Management: Follows initial management of SAH; FASTS HUGS IN BED Please applies; certain aspects have particular relevance
SAH initial management includes: resuscitation; specific treatment; supportive care and monitoring; disposition
Subarachnoid Haemorrhage (SAH) potentially fatal bleeding into the subarachnoid space, usually due to a ruptured cerebral aneurysm
Subarachnoid Haemorrhage: Prognostication - some factors are modifiable; mortality rates currently ~35%; 15% die prior to reaching hospital; 8-20% long-term dependence
Bacterial ventriculitis (BV) is inflammation of the ventricular drainage system, usually due to bacterial infection of the cerebrospinal fluid (CSF)
Vasospasm in SAH: vasospasm = dynamic narrowing of vessels due to a radiological diagnosis; delayed neurological deterioration (DND) is clinically detected neurological deterioration after stabilisation not due to re-bleeding, may be due to multiple other causes; delayed cerebral ischaemia (DCI) is any neurological deterioration >1 hour that presumed due to ischemia, and other causes excluded
Scleroderma = autoimmune mediated widespread collagenous deposition. Limited form: Calcinosis, Raynauds, Esophageal dysfunction, Sclerodacytaly and Telangiectasia (CREST syndrome)
Systemic Lupus Erythematosus (SLE) = chronic, multi-system disease commonest in young females; wide spread antibodies -> produce tissue damage